合計 50 件の最近のインサイダー取引記録が記録されています Veracyte, Inc. (VCYT), 内訳は 7 件の買い および 42 件の売り. インサイダー買い総額は RSU アワード インサイダー売り総額は $11.45M.
最近活動のある主要インサイダーには Haas Kevin Richard, Stapley Marc, Wygant Jonathan. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — VCYT
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-03-24 |
Haas Kevin Richard |
Officer |
不明 |
- |
- |
- |
- |
| 2026-03-06 |
Stapley Marc |
Chief Executive Officer |
RSU 付与（制限付株式） |
92,099 |
- |
- |
449,653 |
| 2026-03-06 |
Wygant Jonathan |
VP, Chief Accounting Officer |
RSU 付与（制限付株式） |
10,525 |
- |
- |
45,434 |
| 2026-03-06 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
RSU 付与（制限付株式） |
29,603 |
- |
- |
146,949 |
| 2026-03-06 |
Chambers Rebecca |
Chief Financial Officer |
RSU 付与（制限付株式） |
36,181 |
- |
- |
167,377 |
| 2026-03-06 |
Mcguire Annie |
SVP, General Counsel |
RSU 付与（制限付株式） |
32,892 |
- |
- |
127,598 |
| 2026-03-06 |
Leite John |
Chief Commercial Officer-clia |
RSU 付与（制限付株式） |
36,181 |
- |
- |
143,761 |
| 2026-03-04 |
Stapley Marc |
Chief Executive Officer |
情報に基づく売り |
26,279 |
$36.28 |
$953.37K |
357,554 |
| 2026-03-04 |
Chambers Rebecca |
Chief Financial Officer |
情報に基づく売り |
13,941 |
$36.33 |
$506.46K |
131,196 |
| 2026-03-04 |
Mcguire Annie |
SVP, General Counsel |
情報に基づく売り |
1,664 |
$36.34 |
$60.47K |
94,706 |
| 2026-03-04 |
Leite John |
Chief Commercial Officer-clia |
情報に基づく売り |
5,260 |
$35.19 |
$185.08K |
107,580 |
| 2026-03-02 |
Stapley Marc |
Chief Executive Officer |
RSU 源泉徴収 |
19,455 |
$36.01 |
$700.57K |
403,077 |
| 2026-03-02 |
Wygant Jonathan |
VP, Chief Accounting Officer |
RSU 源泉徴収 |
3,006 |
$36.01 |
$108.25K |
34,909 |
| 2026-03-02 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
情報に基づく売り |
13,425 |
$36.16 |
$485.43K |
117,346 |
| 2026-03-02 |
Chambers Rebecca |
Chief Financial Officer |
RSU 源泉徴収 |
7,234 |
$36.01 |
$260.5K |
149,537 |
| 2026-03-02 |
Mcguire Annie |
SVP, General Counsel |
RSU 源泉徴収 |
6,902 |
$36.01 |
$248.54K |
101,364 |
| 2026-03-02 |
Leite John |
Chief Commercial Officer-clia |
RSU 源泉徴収 |
7,517 |
$36.01 |
$270.69K |
112,840 |
| 2026-02-26 |
Stapley Marc |
Chief Executive Officer |
RSU 源泉徴収 |
35,841 |
$38.75 |
$1.39M |
422,532 |
| 2026-02-26 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
RSU 源泉徴収 |
24,486 |
$38.75 |
$948.83K |
136,806 |
| 2026-02-26 |
Chambers Rebecca |
Chief Financial Officer |
RSU 源泉徴収 |
12,049 |
$38.75 |
$466.9K |
156,771 |
| 2026-02-26 |
Mcguire Annie |
SVP, General Counsel |
RSU 源泉徴収 |
10,867 |
$38.75 |
$421.1K |
108,266 |
| 2026-02-26 |
Leite John |
Chief Commercial Officer-clia |
RSU 源泉徴収 |
8,905 |
$38.75 |
$345.07K |
120,357 |
| 2025-12-16 |
Mcguire Annie |
SVP, General Counsel |
情報に基づく売り |
100 |
$43.68 |
$4.37K |
67,760 |
| 2025-12-05 |
Eastham Karin |
Director |
オプション行使（売却） |
10,000 |
$7.94 |
$79.4K |
- |
| 2025-12-04 |
Stapley Marc |
Chief Executive Officer |
情報に基づく売り |
3,220 |
$47.35 |
$152.46K |
318,603 |
| 2025-12-04 |
Chambers Rebecca |
Chief Financial Officer |
情報に基づく売り |
4,741 |
$47.25 |
$224.01K |
109,496 |
| 2025-12-04 |
Mcguire Annie |
SVP, General Counsel |
情報に基づく売り |
702 |
$47.51 |
$33.35K |
78,499 |
| 2025-12-04 |
Leite John |
Chief Commercial Officer-clia |
情報に基づく売り |
1,278 |
$47.51 |
$60.72K |
82,113 |
| 2025-12-02 |
Stapley Marc |
Chief Executive Officer |
RSU 源泉徴収 |
7,914 |
$46.16 |
$365.31K |
326,271 |
| 2025-12-02 |
Wygant Jonathan |
VP, Chief Accounting Officer |
RSU 源泉徴収 |
1,325 |
$46.16 |
$61.16K |
37,420 |
| 2025-12-02 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
RSU 源泉徴収 |
2,955 |
$46.16 |
$136.4K |
89,486 |
| 2025-12-02 |
Chambers Rebecca |
Chief Financial Officer |
RSU 源泉徴収 |
3,384 |
$46.16 |
$156.21K |
122,774 |
| 2025-12-02 |
Mcguire Annie |
SVP, General Counsel |
RSU 源泉徴収 |
3,052 |
$46.16 |
$140.88K |
79,921 |
| 2025-12-02 |
Leite John |
Chief Commercial Officer-clia |
RSU 源泉徴収 |
2,900 |
$46.16 |
$133.86K |
83,391 |
| 2025-11-25 |
Jones Evan/ Fa |
Director |
情報に基づく売り |
1,106 |
$50.25 |
$55.58K |
29,362 |
| 2025-11-25 |
Leite John |
Chief Commercial Officer-clia |
情報に基づく売り |
2,808 |
$50.00 |
$140.4K |
86,291 |
| 2025-11-20 |
Holstein Jens |
Director |
情報に基づく売り |
1,460 |
$43.21 |
$63.09K |
27,199 |
| 2025-11-10 |
Wygant Jonathan |
VP, Chief Accounting Officer |
情報に基づく売り |
5,102 |
$42.33 |
$215.98K |
38,745 |
| 2025-11-07 |
Wygant Jonathan |
VP, Chief Accounting Officer |
情報に基づく売り |
5,818 |
$40.21 |
$233.93K |
43,847 |
| 2025-11-05 |
Jones Evan/ Fa |
Director |
オプション行使（売却） |
10,000 |
$5.28 |
$52.8K |
- |
| 2025-11-05 |
Eastham Karin |
Director |
情報に基づく売り |
9,674 |
$40.02 |
$387.19K |
13,554 |
| 2025-11-05 |
Chambers Rebecca |
Chief Financial Officer |
情報に基づく売り |
7,000 |
$41.00 |
$287K |
126,158 |
| 2025-11-05 |
Mcguire Annie |
SVP, General Counsel |
情報に基づく売り |
6,466 |
$40.00 |
$258.64K |
82,973 |
| 2025-10-28 |
Wygant Jonathan |
VP, Chief Accounting Officer |
RSU 付与（制限付株式） |
2,886 |
- |
- |
49,665 |
| 2025-10-06 |
Febbo Phillip G. |
Chief Scientific & Med Officer |
情報に基づく売り |
8,349 |
$36.02 |
$300.71K |
92,441 |
| 2025-10-01 |
Epstein Robert S |
Director |
オプション行使（売却） |
10,000 |
$7.94 |
$79.4K |
- |
| 2025-10-01 |
Mcguire Annie |
SVP, General Counsel |
情報に基づく売り |
2,160 |
$35.00 |
$75.61K |
89,439 |
| 2025-10-01 |
Leite John |
Chief Commercial Officer-clia |
情報に基づく売り |
2,539 |
$35.00 |
$88.87K |
89,099 |
| 2025-09-19 |
Mcguire Annie |
SVP, General Counsel |
情報に基づく売り |
2,283 |
$33.69 |
$76.92K |
91,599 |
| 2025-09-04 |
Stapley Marc |
Chief Executive Officer |
情報に基づく売り |
7,667 |
$30.41 |
$233.13K |
334,185 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
